‹ See all categories

New Creative Relevant Search filters Biotechnological Stock Photos and Images  (989) Narrow your search: Vectors | Black & white | Cut Outs Page 1 of 10 Scientist in lab conducting biotechnological experiment Scientist in lab conducting biotechnological experiment https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/scientist-in-lab-conducting-biotechnological-experiment-image184435700.html petri dish witch bacterial culture and bacteriophage plaques in biotechnological laboratory petri dish witch bacterial culture and bacteriophage plaques in biotechnological laboratoryhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/petri-dish-witch-bacterial-culture-and-bacteriophage-plaques-in-biotechnological-laboratory-image345217999.html biotechnological laboratory equipment for research. Flasks, bottles and pipettes with colorful orange green and blue liquids and dna samples biotechnological laboratory equipment for research. Flasks, bottles and pipettes with colorful orange green and blue liquids and dna sampleshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-biotechnological-laboratory-equipment-for-research-flasks-bottles-145062127.html A hand in disposable glove holding up a petri dish with a bacteria culture in the shape of the biohazard symbol in a biotechnology laboratory. A hand in disposable glove holding up a petri dish with a bacteria culture in the shape of the biohazard symbol in a biotechnology laboratory.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/a-hand-in-disposable-glove-holding-up-a-petri-dish-with-a-bacteria-culture-in-the-shape-of-the-biohazard-symbol-in-a-biotechnology-laboratory-image213874672.html Modern scientist working in biotechnological laboratory equipment for research with pipettes and blue and yellow colorful test tube liquids Modern scientist working in biotechnological laboratory equipment for research with pipettes and blue and yellow colorful test tube liquidshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-modern-scientist-working-in-biotechnological-laboratory-equipment-145732061.html Scientist in lab conducting biotechnological experiment Scientist in lab conducting biotechnological experimenthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/scientist-in-lab-conducting-biotechnological-experiment-image331801782.html Biotechnological research in the laboratory Biotechnological research in the laboratoryhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/biotechnological-research-in-the-laboratory-image343787496.html 3D rendering of a conceptual image representing neural networks in artificial intelligence 3D rendering of a conceptual image representing neural networks in artificial intelligencehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/3d-rendering-of-a-conceptual-image-representing-neural-networks-in-artificial-intelligence-image241262732.html Scientist in lab conducting biotechnological experiment Scientist in lab conducting biotechnological experiment https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/scientist-in-lab-conducting-biotechnological-experiment-image213223793.html 3D render representing the concept of Artificial Intelligence 3D render representing the concept of Artificial Intelligencehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-3d-render-representing-the-concept-of-artificial-intelligence-173228036.html Covid-19 RNA vaccine, illustration Covid-19 RNA vaccine, illustrationhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/covid-19-rna-vaccine-illustration-image396938011.html Scientist in lab conducting biotechnological experiment Scientist in lab conducting biotechnological experiment https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/scientist-in-lab-conducting-biotechnological-experiment-image212454726.html Covid-19 RNA vaccine, illustration Covid-19 RNA vaccine, illustrationhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/covid-19-rna-vaccine-illustration-image396937874.html Modern scientist working in biotechnological laboratory equipment for research with pipettes and blue and yellow colorful test tube liquids Modern scientist working in biotechnological laboratory equipment for research with pipettes and blue and yellow colorful test tube liquidshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-modern-scientist-working-in-biotechnological-laboratory-equipment-145732057.html Botanical research, conceptual image. Botanical research, conceptual image.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/botanical-research-conceptual-image-image330963372.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081495.html Havana. 9th June, 2017. Image taken on June 9, 2017 shows a researcher working at Cuba's Center for Molecular Immunology(CIM) in Havana. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. Credit: Joaquin Hernandez/Xinhua/Alamy Live News Havana. 9th June, 2017. Image taken on June 9, 2017 shows a researcher working at Cuba's Center for Molecular Immunology(CIM) in Havana. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. Credit: Joaquin Hernandez/Xinhua/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-havana-9th-june-2017-image-taken-on-june-9-2017-shows-a-researcher-146653886.html Conceptual image of genetic engineering and modification of food. Conceptual image of genetic engineering and modification of food.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/conceptual-image-of-genetic-engineering-and-modification-of-food-image330963379.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081523.html Havana. 9th June, 2017. Photo taken on June 9, 2017 shows a researcher working at Cuba's Center for Molecular Immunology(CIM) in Havana. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. Credit: Joaquin Hernandez/Xinhua/Alamy Live News Havana. 9th June, 2017. Photo taken on June 9, 2017 shows a researcher working at Cuba's Center for Molecular Immunology(CIM) in Havana. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. Credit: Joaquin Hernandez/Xinhua/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-havana-9th-june-2017-photo-taken-on-june-9-2017-shows-a-researcher-146653893.html Conceptual image of plant research and genetic engineering. Seedlings growing in the laboratory. Conceptual image of plant research and genetic engineering. Seedlings growing in the laboratory.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/conceptual-image-of-plant-research-and-genetic-engineering-seedlings-growing-in-the-laboratory-image330963345.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081525.html Havana. 20th June, 2017. Photo taken on June 20, 2017 shows a researcher working at Cuba's Center for Genetic Engineering and Biotechnology (CIGB) in Havana. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. Credit: Joaquin Hernandez/Xinhua/Alamy Live News Havana. 20th June, 2017. Photo taken on June 20, 2017 shows a researcher working at Cuba's Center for Genetic Engineering and Biotechnology (CIGB) in Havana. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. Credit: Joaquin Hernandez/Xinhua/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-havana-20th-june-2017-photo-taken-on-june-20-2017-shows-a-researcher-146653892.html ST PETERSBURG, RUSSIA – SEPTEMBER 17, 2020: An outside view of the building of Biocad, a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Alexander Demianchuk/TASS ST PETERSBURG, RUSSIA – SEPTEMBER 17, 2020: An outside view of the building of Biocad, a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Alexander Demianchuk/TASShttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-september-17-2020-an-outside-view-of-the-building-of-biocad-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-alexander-demianchuktass-image374146453.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081489.html Havana. 20th June, 2017. Photo taken on June 20, 2017 shows a researcher working at Cuba's Center for Genetic Engineering and Biotechnology (CIGB) in Havana. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. Credit: Joaquin Hernandez/Xinhua/Alamy Live News Havana. 20th June, 2017. Photo taken on June 20, 2017 shows a researcher working at Cuba's Center for Genetic Engineering and Biotechnology (CIGB) in Havana. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. Credit: Joaquin Hernandez/Xinhua/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-havana-20th-june-2017-photo-taken-on-june-20-2017-shows-a-researcher-146653895.html ST PETERSBURG, RUSSIA – SEPTEMBER 17, 2020: Employees at work in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Alexander Demianchuk/TASS ST PETERSBURG, RUSSIA – SEPTEMBER 17, 2020: Employees at work in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Alexander Demianchuk/TASShttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-september-17-2020-employees-at-work-in-a-biocad-chemical-analysis-laboratory-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-alexander-demianchuktass-image374111018.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081521.html Havana. 20th June, 2017. Photo taken on June 20, 2017 shows boxes of Heberprot-P, a medication created in 2006 for treating diabetic foot ulcers, at the Center for Genetic Engineering and Biotechnology (CIGB) in Havana, Cuba. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. Credit: Joaquin Hernandez/Xinhua/Alamy Live News Havana. 20th June, 2017. Photo taken on June 20, 2017 shows boxes of Heberprot-P, a medication created in 2006 for treating diabetic foot ulcers, at the Center for Genetic Engineering and Biotechnology (CIGB) in Havana, Cuba. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. Credit: Joaquin Hernandez/Xinhua/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-havana-20th-june-2017-photo-taken-on-june-20-2017-shows-boxes-of-heberprot-146653889.html ST PETERSBURG, RUSSIA – SEPTEMBER 17, 2020: An employee performs quality control procedures in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Alexander Demianchuk/TASS ST PETERSBURG, RUSSIA – SEPTEMBER 17, 2020: An employee performs quality control procedures in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Alexander Demianchuk/TASShttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-september-17-2020-an-employee-performs-quality-control-procedures-in-a-biocad-chemical-analysis-laboratory-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-alexander-demianchuktass-image374144408.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081531.html 04 February 2020, Mecklenburg-Western Pomerania, Greifswald: German Chancellor Angela Merkel (CDU) visits the biotechnological centre of neoplan tools and has the newly developed kINPen for wound healing in patients explained to her. Photo: Jens Büttner/dpa-Zentralbild/ZB 04 February 2020, Mecklenburg-Western Pomerania, Greifswald: German Chancellor Angela Merkel (CDU) visits the biotechnological centre of neoplan tools and has the newly developed kINPen for wound healing in patients explained to her. Photo: Jens Büttner/dpa-Zentralbild/ZBhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/04-february-2020-mecklenburg-western-pomerania-greifswald-german-chancellor-angela-merkel-cdu-visits-the-biotechnological-centre-of-neoplan-tools-and-has-the-newly-developed-kinpen-for-wound-healing-in-patients-explained-to-her-photo-jens-bttnerdpa-zentralbildzb-image344293202.html St Petersburg, Russia. 17th Sep, 2020. An employees in Biocad's department for genetically engineered therapeutic agents. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. An employees in Biocad's department for genetically engineered therapeutic agents. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-an-employees-in-biocads-department-for-genetically-engineered-therapeutic-agents-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374128269.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081471.html 04 February 2020, Mecklenburg-Western Pomerania, Greifswald: German Chancellor Angela Merkel (CDU) visits the biotechnological centre of neoplan tools and has the newly developed kINPen for wound healing in patients explained to her. Photo: Jens Büttner/dpa-Zentralbild/ZB 04 February 2020, Mecklenburg-Western Pomerania, Greifswald: German Chancellor Angela Merkel (CDU) visits the biotechnological centre of neoplan tools and has the newly developed kINPen for wound healing in patients explained to her. Photo: Jens Büttner/dpa-Zentralbild/ZBhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/04-february-2020-mecklenburg-western-pomerania-greifswald-german-chancellor-angela-merkel-cdu-visits-the-biotechnological-centre-of-neoplan-tools-and-has-the-newly-developed-kinpen-for-wound-healing-in-patients-explained-to-her-photo-jens-bttnerdpa-zentralbildzb-image344293164.html St Petersburg, Russia. 17th Sep, 2020. Employees in the Biocad's department for genetically engineered therapeutic agents. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. Employees in the Biocad's department for genetically engineered therapeutic agents. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-employees-in-the-biocads-department-for-genetically-engineered-therapeutic-agents-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374128274.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081496.html Moscow, Russia. 28th May, 2019. MOSCOW, RUSSIA - MAY 28, 2019: Biotechnological scientist Mikhail Kirpichnikov attends a joint meeting of the Presidium of the Russian Academy of Sciences and the Russian Historical Society. Gavriil Grigorov/TASS Credit: ITAR-TASS News Agency/Alamy Live News Moscow, Russia. 28th May, 2019. MOSCOW, RUSSIA - MAY 28, 2019: Biotechnological scientist Mikhail Kirpichnikov attends a joint meeting of the Presidium of the Russian Academy of Sciences and the Russian Historical Society. Gavriil Grigorov/TASS Credit: ITAR-TASS News Agency/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/moscow-russia-28th-may-2019-moscow-russia-may-28-2019-biotechnological-scientist-mikhail-kirpichnikov-attends-a-joint-meeting-of-the-presidium-of-the-russian-academy-of-sciences-and-the-russian-historical-society-gavriil-grigorovtass-credit-itar-tass-news-agencyalamy-live-news-image247643941.html Leipzig, Germany. 31st Aug, 2020. An employee of the University of Leipzig is holding a pack with a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Credit: Sebastian Willnow/dpa-Zentralbild/dpa/Alamy Live News Leipzig, Germany. 31st Aug, 2020. An employee of the University of Leipzig is holding a pack with a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Credit: Sebastian Willnow/dpa-Zentralbild/dpa/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/leipzig-germany-31st-aug-2020-an-employee-of-the-university-of-leipzig-is-holding-a-pack-with-a-new-corona-antibody-test-the-test-was-developed-in-cooperation-with-the-biotechnological-biomedical-centre-of-the-university-of-leipzig-and-adversis-pharma-gmbh-the-test-provides-users-with-certainty-as-to-whether-or-not-they-have-already-been-infected-with-the-corona-virus-credit-sebastian-willnowdpa-zentralbilddpaalamy-live-news-image370216085.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081483.html St Petersburg, Russia. 17th Sep, 2020. A Biocad employee in a room with cell culture bioreactors. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. A Biocad employee in a room with cell culture bioreactors. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-a-biocad-employee-in-a-room-with-cell-culture-bioreactors-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374139377.html Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) visits the Enzymical company in the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: dpa picture alliance/Alamy Live News Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) visits the Enzymical company in the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: dpa picture alliance/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/greifswald-germany-04th-feb-2020-german-chancellor-angela-merkel-cdu-visits-the-enzymical-company-in-the-biotechnological-centre-prior-to-this-merkel-laid-the-foundation-stone-for-the-new-centre-for-life-science-and-plasma-technology-sand-the-total-investment-amounts-to-more-than-117-million-euros-240-jobs-will-be-created-credit-dpa-picture-alliancealamy-live-news-image342258980.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081474.html St Petersburg, Russia. 17th Sep, 2020. A Biocad employee in a room with cell culture bioreactors. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. A Biocad employee in a room with cell culture bioreactors. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-a-biocad-employee-in-a-room-with-cell-culture-bioreactors-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374138503.html Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) visits start-up companies in the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: dpa picture alliance/Alamy Live News Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) visits start-up companies in the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: dpa picture alliance/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/greifswald-germany-04th-feb-2020-german-chancellor-angela-merkel-cdu-visits-start-up-companies-in-the-biotechnological-centre-prior-to-this-merkel-laid-the-foundation-stone-for-the-new-centre-for-life-science-and-plasma-technology-sand-the-total-investment-amounts-to-more-than-117-million-euros-240-jobs-will-be-created-credit-dpa-picture-alliancealamy-live-news-image342259016.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081468.html St Petersburg, Russia. 17th Sep, 2020. Employees operate filling machines in a production facility of Biocad. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. Employees operate filling machines in a production facility of Biocad. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-employees-operate-filling-machines-in-a-production-facility-of-biocad-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374323037.html Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) visits the Enzymical company in the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: dpa picture alliance/Alamy Live News Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) visits the Enzymical company in the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: dpa picture alliance/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/greifswald-germany-04th-feb-2020-german-chancellor-angela-merkel-cdu-visits-the-enzymical-company-in-the-biotechnological-centre-prior-to-this-merkel-laid-the-foundation-stone-for-the-new-centre-for-life-science-and-plasma-technology-sand-the-total-investment-amounts-to-more-than-117-million-euros-240-jobs-will-be-created-credit-dpa-picture-alliancealamy-live-news-image342258977.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081500.html St Petersburg, Russia. 17th Sep, 2020. Employees in a laboratory of Biocad's department for genetically engineered therapeutic agents. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. Employees in a laboratory of Biocad's department for genetically engineered therapeutic agents. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-employees-in-a-laboratory-of-biocads-department-for-genetically-engineered-therapeutic-agents-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374129081.html Leipzig, Germany. 31st Aug, 2020. Sebastian Gemkow (CDU), Minister of Science of the State of Saxony, completes a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Credit: Sebastian Willnow/dpa-Zentralbild/dpa/Alamy Live News Leipzig, Germany. 31st Aug, 2020. Sebastian Gemkow (CDU), Minister of Science of the State of Saxony, completes a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Credit: Sebastian Willnow/dpa-Zentralbild/dpa/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/leipzig-germany-31st-aug-2020-sebastian-gemkow-cdu-minister-of-science-of-the-state-of-saxony-completes-a-new-corona-antibody-test-the-test-was-developed-in-cooperation-with-the-biotechnological-biomedical-centre-of-the-university-of-leipzig-and-adversis-pharma-gmbh-the-test-provides-users-with-certainty-as-to-whether-or-not-they-have-already-been-infected-with-the-corona-virus-credit-sebastian-willnowdpa-zentralbilddpaalamy-live-news-image370216077.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081536.html St Petersburg, Russia. 17th Sep, 2020. A Biocad employee in a room with systems for protein secretion and viral filtration. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. A Biocad employee in a room with systems for protein secretion and viral filtration. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-a-biocad-employee-in-a-room-with-systems-for-protein-secretion-and-viral-filtration-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374143595.html Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU, l) has the newly developed kINPen for wound healing in patients explained by Ulrike Sailer, Managing Director of neoplan tools, during a visit to the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. Credit: dpa picture alliance/Alamy Live News Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU, l) has the newly developed kINPen for wound healing in patients explained by Ulrike Sailer, Managing Director of neoplan tools, during a visit to the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. Credit: dpa picture alliance/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/greifswald-germany-04th-feb-2020-german-chancellor-angela-merkel-cdu-l-has-the-newly-developed-kinpen-for-wound-healing-in-patients-explained-by-ulrike-sailer-managing-director-of-neoplan-tools-during-a-visit-to-the-biotechnological-centre-prior-to-this-merkel-laid-the-foundation-stone-for-the-new-centre-for-life-science-and-plasma-technology-sand-credit-dpa-picture-alliancealamy-live-news-image342259010.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081469.html St Petersburg, Russia. 17th Sep, 2020. An employee performs quality control procedures in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. An employee performs quality control procedures in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-an-employee-performs-quality-control-procedures-in-a-biocad-chemical-analysis-laboratory-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374113648.html Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU, l) has the newly developed kINPen for wound healing in patients explained by Ulrike Sailer, Managing Director of neoplan tools, during a visit to the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. Credit: dpa picture alliance/Alamy Live News Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU, l) has the newly developed kINPen for wound healing in patients explained by Ulrike Sailer, Managing Director of neoplan tools, during a visit to the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. Credit: dpa picture alliance/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/greifswald-germany-04th-feb-2020-german-chancellor-angela-merkel-cdu-l-has-the-newly-developed-kinpen-for-wound-healing-in-patients-explained-by-ulrike-sailer-managing-director-of-neoplan-tools-during-a-visit-to-the-biotechnological-centre-prior-to-this-merkel-laid-the-foundation-stone-for-the-new-centre-for-life-science-and-plasma-technology-sand-credit-dpa-picture-alliancealamy-live-news-image342258997.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081522.html St Petersburg, Russia. 17th Sep, 2020. A biochemical analysis team member in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. A biochemical analysis team member in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-a-biochemical-analysis-team-member-in-a-biocad-chemical-analysis-laboratory-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374108517.html Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU, l) has the newly developed kINPen for wound healing in patients explained by Ulrike Sailer, Managing Director of neoplan tools, during a visit to the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. Credit: dpa picture alliance/Alamy Live News Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU, l) has the newly developed kINPen for wound healing in patients explained by Ulrike Sailer, Managing Director of neoplan tools, during a visit to the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. Credit: dpa picture alliance/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/greifswald-germany-04th-feb-2020-german-chancellor-angela-merkel-cdu-l-has-the-newly-developed-kinpen-for-wound-healing-in-patients-explained-by-ulrike-sailer-managing-director-of-neoplan-tools-during-a-visit-to-the-biotechnological-centre-prior-to-this-merkel-laid-the-foundation-stone-for-the-new-centre-for-life-science-and-plasma-technology-sand-credit-dpa-picture-alliancealamy-live-news-image342259011.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081480.html St Petersburg, Russia. 17th Sep, 2020. An employee in a laboratory of Biocad's department for pharmaceutical development of genetically engineered therapeutic agents. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. An employee in a laboratory of Biocad's department for pharmaceutical development of genetically engineered therapeutic agents. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-an-employee-in-a-laboratory-of-biocads-department-for-pharmaceutical-development-of-genetically-engineered-therapeutic-agents-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374132353.html Leipzig, Germany. 31st Aug, 2020. Sebastian Gemkow (CDU), Minister of Science of Saxony, shows the test card with blood for a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Credit: Sebastian Willnow/dpa-Zentralbild/dpa/Alamy Live News Leipzig, Germany. 31st Aug, 2020. Sebastian Gemkow (CDU), Minister of Science of Saxony, shows the test card with blood for a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Credit: Sebastian Willnow/dpa-Zentralbild/dpa/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/leipzig-germany-31st-aug-2020-sebastian-gemkow-cdu-minister-of-science-of-saxony-shows-the-test-card-with-blood-for-a-new-corona-antibody-test-the-test-was-developed-in-cooperation-with-the-biotechnological-biomedical-centre-of-the-university-of-leipzig-and-adversis-pharma-gmbh-the-test-provides-users-with-certainty-as-to-whether-or-not-they-have-already-been-infected-with-the-corona-virus-credit-sebastian-willnowdpa-zentralbilddpaalamy-live-news-image370216096.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081499.html St Petersburg, Russia. 17th Sep, 2020. A Biocad employee in a room with piping systems for water for injection and highly purified water. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live News St Petersburg, Russia. 17th Sep, 2020. A Biocad employee in a room with piping systems for water for injection and highly purified water. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Credit: Alexander Demianchuk/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-17th-sep-2020-a-biocad-employee-in-a-room-with-piping-systems-for-water-for-injection-and-highly-purified-water-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-credit-alexander-demianchuktassalamy-live-news-image374137691.html Leipzig, Germany. 31st Aug, 2020. Sebastian Gemkow (CDU), Science Minister of the State of Saxony, takes blood for a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Credit: Sebastian Willnow/dpa-Zentralbild/dpa/Alamy Live News Leipzig, Germany. 31st Aug, 2020. Sebastian Gemkow (CDU), Science Minister of the State of Saxony, takes blood for a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Credit: Sebastian Willnow/dpa-Zentralbild/dpa/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/leipzig-germany-31st-aug-2020-sebastian-gemkow-cdu-science-minister-of-the-state-of-saxony-takes-blood-for-a-new-corona-antibody-test-the-test-was-developed-in-cooperation-with-the-biotechnological-biomedical-centre-of-the-university-of-leipzig-and-adversis-pharma-gmbh-the-test-provides-users-with-certainty-as-to-whether-or-not-they-have-already-been-infected-with-the-corona-virus-credit-sebastian-willnowdpa-zentralbilddpaalamy-live-news-image370216082.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081528.html St Petersburg, Russia. 25th Dec, 2020. Russia's Prime Minister Mikhail Mishustin visits a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live News St Petersburg, Russia. 25th Dec, 2020. Russia's Prime Minister Mikhail Mishustin visits a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-25th-dec-2020-russias-prime-minister-mikhail-mishustin-visits-a-research-and-development-centre-of-the-biocad-biotechnology-company-in-strelna-biocad-combines-a-research-and-development-centre-pharmaceutical-and-biotechnological-manufacturing-facilities-and-preclinical-and-clinical-research-infrastructure-credit-dmitry-astakhovpooltassalamy-live-news-image395472752.html Leipzig, Germany. 31st Aug, 2020. Sebastian Gemkow (CDU), Minister of Science of Saxony, shows the test card with blood for a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Credit: Sebastian Willnow/dpa-Zentralbild/dpa/Alamy Live News Leipzig, Germany. 31st Aug, 2020. Sebastian Gemkow (CDU), Minister of Science of Saxony, shows the test card with blood for a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Credit: Sebastian Willnow/dpa-Zentralbild/dpa/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/leipzig-germany-31st-aug-2020-sebastian-gemkow-cdu-minister-of-science-of-saxony-shows-the-test-card-with-blood-for-a-new-corona-antibody-test-the-test-was-developed-in-cooperation-with-the-biotechnological-biomedical-centre-of-the-university-of-leipzig-and-adversis-pharma-gmbh-the-test-provides-users-with-certainty-as-to-whether-or-not-they-have-already-been-infected-with-the-corona-virus-credit-sebastian-willnowdpa-zentralbilddpaalamy-live-news-image370216099.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081472.html St Petersburg, Russia. 25th Dec, 2020. Russia's Prime Minister Mikhail Mishustin visits a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live News St Petersburg, Russia. 25th Dec, 2020. Russia's Prime Minister Mikhail Mishustin visits a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-25th-dec-2020-russias-prime-minister-mikhail-mishustin-visits-a-research-and-development-centre-of-the-biocad-biotechnology-company-in-strelna-biocad-combines-a-research-and-development-centre-pharmaceutical-and-biotechnological-manufacturing-facilities-and-preclinical-and-clinical-research-infrastructure-credit-dmitry-astakhovpooltassalamy-live-news-image395469777.html Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) has the CEO Ulrike Sailer of neoplan tools explain the newly developed kINPen for wound healing in patients during a visit to the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: dpa picture alliance/Alamy Live News Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) has the CEO Ulrike Sailer of neoplan tools explain the newly developed kINPen for wound healing in patients during a visit to the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new Centre for Life Science and Plasma Technology Sand. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: dpa picture alliance/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/greifswald-germany-04th-feb-2020-german-chancellor-angela-merkel-cdu-has-the-ceo-ulrike-sailer-of-neoplan-tools-explain-the-newly-developed-kinpen-for-wound-healing-in-patients-during-a-visit-to-the-biotechnological-centre-prior-to-this-merkel-laid-the-foundation-stone-for-the-new-centre-for-life-science-and-plasma-technology-sand-the-total-investment-amounts-to-more-than-117-million-euros-240-jobs-will-be-created-credit-dpa-picture-alliancealamy-live-news-image342259005.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081497.html St Petersburg, Russia. 25th Dec, 2020. Russia's Prime Minister Mikhail Mishustin visit a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live News St Petersburg, Russia. 25th Dec, 2020. Russia's Prime Minister Mikhail Mishustin visit a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-25th-dec-2020-russias-prime-minister-mikhail-mishustin-visit-a-research-and-development-centre-of-the-biocad-biotechnology-company-in-strelna-biocad-combines-a-research-and-development-centre-pharmaceutical-and-biotechnological-manufacturing-facilities-and-preclinical-and-clinical-research-infrastructure-credit-dmitry-astakhovpooltassalamy-live-news-image395469766.html Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) visits the Enzymical company in the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new centre for life science and plasma technology. The start-up centre is intended to give young companies the opportunity to implement their ideas in the fields of bioeconomy and plasma technology. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: Jens Büttner/dpa-Zentralbild/ZB/dpa/Alamy Live News Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) visits the Enzymical company in the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new centre for life science and plasma technology. The start-up centre is intended to give young companies the opportunity to implement their ideas in the fields of bioeconomy and plasma technology. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: Jens Büttner/dpa-Zentralbild/ZB/dpa/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/greifswald-germany-04th-feb-2020-german-chancellor-angela-merkel-cdu-visits-the-enzymical-company-in-the-biotechnological-centre-prior-to-this-merkel-laid-the-foundation-stone-for-the-new-centre-for-life-science-and-plasma-technology-the-start-up-centre-is-intended-to-give-young-companies-the-opportunity-to-implement-their-ideas-in-the-fields-of-bioeconomy-and-plasma-technology-the-total-investment-amounts-to-more-than-117-million-euros-240-jobs-will-be-created-credit-jens-bttnerdpa-zentralbildzbdpaalamy-live-news-image344294863.html Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081494.html St Petersburg, Russia. 25th Dec, 2020. Russia's Prime Minister Mikhail Mishustin visits a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live News St Petersburg, Russia. 25th Dec, 2020. Russia's Prime Minister Mikhail Mishustin visits a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-25th-dec-2020-russias-prime-minister-mikhail-mishustin-visits-a-research-and-development-centre-of-the-biocad-biotechnology-company-in-strelna-biocad-combines-a-research-and-development-centre-pharmaceutical-and-biotechnological-manufacturing-facilities-and-preclinical-and-clinical-research-infrastructure-credit-dmitry-astakhovpooltassalamy-live-news-image395472770.html Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) visits the Enzymical company in the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new centre for life science and plasma technology. The start-up centre is intended to give young companies the opportunity to implement their ideas in the fields of bioeconomy and plasma technology. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: Jens Büttner/dpa-Zentralbild/ZB/dpa/Alamy Live News Greifswald, Germany. 04th Feb, 2020. German Chancellor Angela Merkel (CDU) visits the Enzymical company in the biotechnological centre. Prior to this, Merkel laid the foundation stone for the new centre for life science and plasma technology. The start-up centre is intended to give young companies the opportunity to implement their ideas in the fields of bioeconomy and plasma technology. The total investment amounts to more than 117 million euros, 240 jobs will be created. Credit: Jens Büttner/dpa-Zentralbild/ZB/dpa/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/greifswald-germany-04th-feb-2020-german-chancellor-angela-merkel-cdu-visits-the-enzymical-company-in-the-biotechnological-centre-prior-to-this-merkel-laid-the-foundation-stone-for-the-new-centre-for-life-science-and-plasma-technology-the-start-up-centre-is-intended-to-give-young-companies-the-opportunity-to-implement-their-ideas-in-the-fields-of-bioeconomy-and-plasma-technology-the-total-investment-amounts-to-more-than-117-million-euros-240-jobs-will-be-created-credit-jens-bttnerdpa-zentralbildzbdpaalamy-live-news-image344294864.html Microscope, Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Microscope, Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/microscope-enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081467.html ST PETERSBURG, RUSSIA – SEPTEMBER 17, 2020: Levilimab (marketed under the name of Ilsira), an inhibitor of the interleukin-6 glycoprotein used for treating COVID-19 complications, is seen in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Alexander Demianchuk/TASS ST PETERSBURG, RUSSIA – SEPTEMBER 17, 2020: Levilimab (marketed under the name of Ilsira), an inhibitor of the interleukin-6 glycoprotein used for treating COVID-19 complications, is seen in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Alexander Demianchuk/TASShttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-september-17-2020-levilimab-marketed-under-the-name-of-ilsira-an-inhibitor-of-the-interleukin-6-glycoprotein-used-for-treating-covid-19-complications-is-seen-in-a-biocad-chemical-analysis-laboratory-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-alexander-demianchuktass-image374125396.html 31 August 2020, Saxony, Leipzig: Michael Kretschmer (CDU, l-r), Prime Minister of the State of Saxony, Ralf Hoffmann from the Biotechnological-Biomedical Centre (BBZ) at the University of Leipzig and Jörg Gaber, Managing Director of Adversis Pharma GmbH, hold packages containing a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Photo: Sebastian Willnow/dpa-Zentralbild 31 August 2020, Saxony, Leipzig: Michael Kretschmer (CDU, l-r), Prime Minister of the State of Saxony, Ralf Hoffmann from the Biotechnological-Biomedical Centre (BBZ) at the University of Leipzig and Jörg Gaber, Managing Director of Adversis Pharma GmbH, hold packages containing a new corona antibody test. The test was developed in cooperation with the Biotechnological-Biomedical Centre of the University of Leipzig and Adversis Pharma GmbH. The test provides users with certainty as to whether or not they have already been infected with the corona virus. Photo: Sebastian Willnow/dpa-Zentralbildhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/31-august-2020-saxony-leipzig-michael-kretschmer-cdu-l-r-prime-minister-of-the-state-of-saxony-ralf-hoffmann-from-the-biotechnological-biomedical-centre-bbz-at-the-university-of-leipzig-and-jrg-gaber-managing-director-of-adversis-pharma-gmbh-hold-packages-containing-a-new-corona-antibody-test-the-test-was-developed-in-cooperation-with-the-biotechnological-biomedical-centre-of-the-university-of-leipzig-and-adversis-pharma-gmbh-the-test-provides-users-with-certainty-as-to-whether-or-not-they-have-already-been-infected-with-the-corona-virus-photo-sebastian-willnowdpa-zentralbild-image370216094.html Microscope, Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spain Microscope, Enzyme production, Chemical lab, Biotechnological and industrial applications, Donostia, San Sebastian, Basque Country, Spainhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/microscope-enzyme-production-chemical-lab-biotechnological-and-industrial-applications-donostia-san-sebastian-basque-country-spain-image360081493.html ST PETERSBURG, RUSSIA – SEPTEMBER 17, 2020: Levilimab (marketed under the name of Ilsira), an inhibitor of the interleukin-6 glycoprotein used for treating COVID-19 complications, is seen in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Alexander Demianchuk/TASS ST PETERSBURG, RUSSIA – SEPTEMBER 17, 2020: Levilimab (marketed under the name of Ilsira), an inhibitor of the interleukin-6 glycoprotein used for treating COVID-19 complications, is seen in a Biocad chemical analysis laboratory. Biocad is a Russian innovative biotechnology company that combines a research and development centre and pharmaceutical and biotechnological manufacturing facilities. Alexander Demianchuk/TASShttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-september-17-2020-levilimab-marketed-under-the-name-of-ilsira-an-inhibitor-of-the-interleukin-6-glycoprotein-used-for-treating-covid-19-complications-is-seen-in-a-biocad-chemical-analysis-laboratory-biocad-is-a-russian-innovative-biotechnology-company-that-combines-a-research-and-development-centre-and-pharmaceutical-and-biotechnological-manufacturing-facilities-alexander-demianchuktass-image374124537.html 29 July 2020, Saxony-Anhalt, Halle (Saale): Vitali Jakobi is working on a bioreactor in the Navigo Proteins laboratory. The biotechnology company is based in the Weinberg Campus Technology Park, which the Minister of Economic Affairs of Saxony-Anhalt has now awarded the Weinberg Campus as a 'future location' during a visit. Navigo Proteins was founded in 1999. With its 50 employees, the company specialises in the development of proteins that are used in biotherapeutic, diagnostic and biotechnological applications. Currently, the company is also involved in drug research against the coronavirus 29 July 2020, Saxony-Anhalt, Halle (Saale): Vitali Jakobi is working on a bioreactor in the Navigo Proteins laboratory. The biotechnology company is based in the Weinberg Campus Technology Park, which the Minister of Economic Affairs of Saxony-Anhalt has now awarded the Weinberg Campus as a 'future location' during a visit. Navigo Proteins was founded in 1999. With its 50 employees, the company specialises in the development of proteins that are used in biotherapeutic, diagnostic and biotechnological applications. Currently, the company is also involved in drug research against the coronavirushttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/29-july-2020-saxony-anhalt-halle-saale-vitali-jakobi-is-working-on-a-bioreactor-in-the-navigo-proteins-laboratory-the-biotechnology-company-is-based-in-the-weinberg-campus-technology-park-which-the-minister-of-economic-affairs-of-saxony-anhalt-has-now-awarded-the-weinberg-campus-as-a-future-location-during-a-visit-navigo-proteins-was-founded-in-1999-with-its-50-employees-the-company-specialises-in-the-development-of-proteins-that-are-used-in-biotherapeutic-diagnostic-and-biotechnological-applications-currently-the-company-is-also-involved-in-drug-research-against-the-coronavirus-image367141920.html St Petersburg, Russia. 25th Dec, 2020. Russia's Prime Minister Mikhail Mishustin speaks during a visit to a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live News St Petersburg, Russia. 25th Dec, 2020. Russia's Prime Minister Mikhail Mishustin speaks during a visit to a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-25th-dec-2020-russias-prime-minister-mikhail-mishustin-speaks-during-a-visit-to-a-research-and-development-centre-of-the-biocad-biotechnology-company-in-strelna-biocad-combines-a-research-and-development-centre-pharmaceutical-and-biotechnological-manufacturing-facilities-and-preclinical-and-clinical-research-infrastructure-credit-dmitry-astakhovpooltassalamy-live-news-image395479999.html German Chancellor Angela Merkel talks at the opening of the new Fraunhofer Center for Chemical-Biotechnological Processes (CBP) in Leuna, Germany, 02 October 2012. Scientists at the center research how renewable resources could be used more effectively in chemical industry to replace oil. Photo: Hendrik Schmidt German Chancellor Angela Merkel talks at the opening of the new Fraunhofer Center for Chemical-Biotechnological Processes (CBP) in Leuna, Germany, 02 October 2012. Scientists at the center research how renewable resources could be used more effectively in chemical industry to replace oil. Photo: Hendrik Schmidthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-german-chancellor-angela-merkel-talks-at-the-opening-of-the-new-fraunhofer-55256441.html 29 July 2020, Saxony-Anhalt, Halle (Saale): Vitali Jakobi is working on a bioreactor in the Navigo Proteins laboratory. The biotechnology company is based in the Weinberg Campus Technology Park, which the Minister of Economic Affairs of Saxony-Anhalt has now awarded the Weinberg Campus as a 'future location' during a visit. Navigo Proteins was founded in 1999. With its 50 employees, the company specialises in the development of proteins that are used in biotherapeutic, diagnostic and biotechnological applications. Currently, the company is also involved in drug research against the coronavirus 29 July 2020, Saxony-Anhalt, Halle (Saale): Vitali Jakobi is working on a bioreactor in the Navigo Proteins laboratory. The biotechnology company is based in the Weinberg Campus Technology Park, which the Minister of Economic Affairs of Saxony-Anhalt has now awarded the Weinberg Campus as a 'future location' during a visit. Navigo Proteins was founded in 1999. With its 50 employees, the company specialises in the development of proteins that are used in biotherapeutic, diagnostic and biotechnological applications. Currently, the company is also involved in drug research against the coronavirushttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/29-july-2020-saxony-anhalt-halle-saale-vitali-jakobi-is-working-on-a-bioreactor-in-the-navigo-proteins-laboratory-the-biotechnology-company-is-based-in-the-weinberg-campus-technology-park-which-the-minister-of-economic-affairs-of-saxony-anhalt-has-now-awarded-the-weinberg-campus-as-a-future-location-during-a-visit-navigo-proteins-was-founded-in-1999-with-its-50-employees-the-company-specialises-in-the-development-of-proteins-that-are-used-in-biotherapeutic-diagnostic-and-biotechnological-applications-currently-the-company-is-also-involved-in-drug-research-against-the-coronavirus-image367141935.html St Petersburg, Russia. 25th Dec, 2020. Biocad general director Dmitry Morozov (L) and Russia's Prime Minister Mikhail Mishustin visit a production facility of the Biocad biotechnology company. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live News St Petersburg, Russia. 25th Dec, 2020. Biocad general director Dmitry Morozov (L) and Russia's Prime Minister Mikhail Mishustin visit a production facility of the Biocad biotechnology company. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-25th-dec-2020-biocad-general-director-dmitry-morozov-l-and-russias-prime-minister-mikhail-mishustin-visit-a-production-facility-of-the-biocad-biotechnology-company-biocad-combines-a-research-and-development-centre-pharmaceutical-and-biotechnological-manufacturing-facilities-and-preclinical-and-clinical-research-infrastructure-credit-dmitry-astakhovpooltassalamy-live-news-image395468214.html German Chancellor Angela Merkel stands in front of a bio reactor inside the new Fraunhofer Center for Chemical-Biotechnological Processes (CBP) in Leuna, Germany, 02 October 2012. Scientists at the center research how renewable resources could be used more effectively in chemical industry to replace oil. Photo: Hendrik Schmidt German Chancellor Angela Merkel stands in front of a bio reactor inside the new Fraunhofer Center for Chemical-Biotechnological Processes (CBP) in Leuna, Germany, 02 October 2012. Scientists at the center research how renewable resources could be used more effectively in chemical industry to replace oil. Photo: Hendrik Schmidthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-german-chancellor-angela-merkel-stands-in-front-of-a-bio-reactor-inside-55256224.html 29 July 2020, Saxony-Anhalt, Halle (Saale): Vitali Jakobi is working on a bioreactor in the Navigo Proteins laboratory. The biotechnology company is based in the Weinberg Campus Technology Park, which the Minister of Economic Affairs of Saxony-Anhalt has now awarded the Weinberg Campus as a 'future location' during a visit. Navigo Proteins was founded in 1999. With its 50 employees, the company specialises in the development of proteins that are used in biotherapeutic, diagnostic and biotechnological applications. Currently, the company is also involved in drug research against the coronavirus 29 July 2020, Saxony-Anhalt, Halle (Saale): Vitali Jakobi is working on a bioreactor in the Navigo Proteins laboratory. The biotechnology company is based in the Weinberg Campus Technology Park, which the Minister of Economic Affairs of Saxony-Anhalt has now awarded the Weinberg Campus as a 'future location' during a visit. Navigo Proteins was founded in 1999. With its 50 employees, the company specialises in the development of proteins that are used in biotherapeutic, diagnostic and biotechnological applications. Currently, the company is also involved in drug research against the coronavirushttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/29-july-2020-saxony-anhalt-halle-saale-vitali-jakobi-is-working-on-a-bioreactor-in-the-navigo-proteins-laboratory-the-biotechnology-company-is-based-in-the-weinberg-campus-technology-park-which-the-minister-of-economic-affairs-of-saxony-anhalt-has-now-awarded-the-weinberg-campus-as-a-future-location-during-a-visit-navigo-proteins-was-founded-in-1999-with-its-50-employees-the-company-specialises-in-the-development-of-proteins-that-are-used-in-biotherapeutic-diagnostic-and-biotechnological-applications-currently-the-company-is-also-involved-in-drug-research-against-the-coronavirus-image367141975.html St Petersburg, Russia. 25th Dec, 2020. Biocad general director Dmitry Morozov (L) and Russia's Prime Minister Mikhail Mishustin visit a research and development centre of the Biocad biotechnology company. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live News St Petersburg, Russia. 25th Dec, 2020. Biocad general director Dmitry Morozov (L) and Russia's Prime Minister Mikhail Mishustin visit a research and development centre of the Biocad biotechnology company. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-25th-dec-2020-biocad-general-director-dmitry-morozov-l-and-russias-prime-minister-mikhail-mishustin-visit-a-research-and-development-centre-of-the-biocad-biotechnology-company-biocad-combines-a-research-and-development-centre-pharmaceutical-and-biotechnological-manufacturing-facilities-and-preclinical-and-clinical-research-infrastructure-credit-dmitry-astakhovpooltassalamy-live-news-image395468201.html Bio-engineer Susanne Zibek checks the production of enzymes on a bioreactor in the new Fraunhofer Center for Chemical-Biotechnological Processes (CBP) in Leuna, Germany, 02 October 2012. Scientists at the center research how renewable resources could be used more effectively in chemical industry to replace oil. Photo: Hendrik Schmidt Bio-engineer Susanne Zibek checks the production of enzymes on a bioreactor in the new Fraunhofer Center for Chemical-Biotechnological Processes (CBP) in Leuna, Germany, 02 October 2012. Scientists at the center research how renewable resources could be used more effectively in chemical industry to replace oil. Photo: Hendrik Schmidthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-bio-engineer-susanne-zibek-checks-the-production-of-enzymes-on-a-bioreactor-55256489.html 29 July 2020, Saxony-Anhalt, Halle (Saale): A system for the transfer of bacterial colonies works in the laboratory of Navigo Proteins. The biotechnology company is based in the Weinberg Campus Technology Park, which the Minister of Economic Affairs of Saxony-Anhalt has now awarded the Weinberg Campus as a 'future location' during a visit. Navigo Proteins was founded in 1999. With its 50 employees, the company specialises in the development of proteins that are used in biotherapeutic, diagnostic and biotechnological applications. Currently, the company is also involved in drug research against 29 July 2020, Saxony-Anhalt, Halle (Saale): A system for the transfer of bacterial colonies works in the laboratory of Navigo Proteins. The biotechnology company is based in the Weinberg Campus Technology Park, which the Minister of Economic Affairs of Saxony-Anhalt has now awarded the Weinberg Campus as a 'future location' during a visit. Navigo Proteins was founded in 1999. With its 50 employees, the company specialises in the development of proteins that are used in biotherapeutic, diagnostic and biotechnological applications. Currently, the company is also involved in drug research againsthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/29-july-2020-saxony-anhalt-halle-saale-a-system-for-the-transfer-of-bacterial-colonies-works-in-the-laboratory-of-navigo-proteins-the-biotechnology-company-is-based-in-the-weinberg-campus-technology-park-which-the-minister-of-economic-affairs-of-saxony-anhalt-has-now-awarded-the-weinberg-campus-as-a-future-location-during-a-visit-navigo-proteins-was-founded-in-1999-with-its-50-employees-the-company-specialises-in-the-development-of-proteins-that-are-used-in-biotherapeutic-diagnostic-and-biotechnological-applications-currently-the-company-is-also-involved-in-drug-research-against-image367141910.html St Petersburg, Russia. 25th Dec, 2020. Biocad general director Dmitry Morozov (L) and Russia's Prime Minister Mikhail Mishustin visit a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live News St Petersburg, Russia. 25th Dec, 2020. Biocad general director Dmitry Morozov (L) and Russia's Prime Minister Mikhail Mishustin visit a research and development centre of the Biocad biotechnology company in Strelna. Biocad combines a research and development centre, pharmaceutical and biotechnological manufacturing facilities, and preclinical and clinical research infrastructure. Credit: Dmitry Astakhov/POOL/TASS/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-25th-dec-2020-biocad-general-director-dmitry-morozov-l-and-russias-prime-minister-mikhail-mishustin-visit-a-research-and-development-centre-of-the-biocad-biotechnology-company-in-strelna-biocad-combines-a-research-and-development-centre-pharmaceutical-and-biotechnological-manufacturing-facilities-and-preclinical-and-clinical-research-infrastructure-credit-dmitry-astakhovpooltassalamy-live-news-image395470850.html The director of the new center Gerd Unkelbach (L-R) talks to German Chancellor Angela Merkel and Saxony-Anhalt's Premier Reiner Haseloff in front of a biorefinery at the new Fraunhofer Center for Chemical-Biotechnological Processes (CBP) in Leuna, Germany, 02 October 2012. Scientists at the center research how renewable resources could be used more effectively in chemical industry The director of the new center Gerd Unkelbach (L-R) talks to German Chancellor Angela Merkel and Saxony-Anhalt's Premier Reiner Haseloff in front of a biorefinery at the new Fraunhofer Center for Chemical-Biotechnological Processes (CBP) in Leuna, Germany, 02 October 2012. Scientists at the center research how renewable resources could be used more effectively in chemical industry https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-the-director-of-the-new-center-gerd-unkelbach-l-r-talks-to-german-55256195.html Russia. 21st Aug, 2019. NOVOSIBIRSK REGION, RUSSIA - AUGUST 21, 2019: A biotechnological control lab at the Research Center research and production company located in the science town of Koltsovo. Research Center develops and produces nutritional supplements, cosmetic formulations, biologically active substances for plants, and the Antoshka blackboard chalks. Kirill Kukhmar/TASS Credit: ITAR-TASS News Agency/Alamy Live News Russia. 21st Aug, 2019. NOVOSIBIRSK REGION, RUSSIA - AUGUST 21, 2019: A biotechnological control lab at the Research Center research and production company located in the science town of Koltsovo. Research Center develops and produces nutritional supplements, cosmetic formulations, biologically active substances for plants, and the Antoshka blackboard chalks. Kirill Kukhmar/TASS Credit: ITAR-TASS News Agency/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/russia-21st-aug-2019-novosibirsk-region-russia-august-21-2019-a-biotechnological-control-lab-at-the-research-center-research-and-production-company-located-in-the-science-town-of-koltsovo-research-center-develops-and-produces-nutritional-supplements-cosmetic-formulations-biologically-active-substances-for-plants-and-the-antoshka-blackboard-chalks-kirill-kukhmartass-credit-itar-tass-news-agencyalamy-live-news-image264701774.html bioreactor in biotechnological laboratory bioreactor in biotechnological laboratoryhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-bioreactor-in-biotechnological-laboratory-132937361.html Bio engineer Susanne Zibek (L) talks to German Chancellor Angela Merkel in front of a bio reactor at the new Fraunhofer Center for Chemical-Biotechnological Processes (CBP) in Leuna, Germany, 02 October 2012. Scientists at the center research how renewable resources could be used more effectively in chemical industry to replace oil. Photo: Hendrik Schmidt Bio engineer Susanne Zibek (L) talks to German Chancellor Angela Merkel in front of a bio reactor at the new Fraunhofer Center for Chemical-Biotechnological Processes (CBP) in Leuna, Germany, 02 October 2012. Scientists at the center research how renewable resources could be used more effectively in chemical industry to replace oil. Photo: Hendrik Schmidthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-bio-engineer-susanne-zibek-l-talks-to-german-chancellor-angela-merkel-55256265.html Russia. 21st Aug, 2019. NOVOSIBIRSK REGION, RUSSIA - AUGUST 21, 2019: A biotechnological control lab at the Research Center research and production company located in the science town of Koltsovo. Research Center develops and produces nutritional supplements, cosmetic formulations, biologically active substances for plants, and the Antoshka blackboard chalks. Kirill Kukhmar/TASS Credit: ITAR-TASS News Agency/Alamy Live News Russia. 21st Aug, 2019. NOVOSIBIRSK REGION, RUSSIA - AUGUST 21, 2019: A biotechnological control lab at the Research Center research and production company located in the science town of Koltsovo. Research Center develops and produces nutritional supplements, cosmetic formulations, biologically active substances for plants, and the Antoshka blackboard chalks. Kirill Kukhmar/TASS Credit: ITAR-TASS News Agency/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/russia-21st-aug-2019-novosibirsk-region-russia-august-21-2019-a-biotechnological-control-lab-at-the-research-center-research-and-production-company-located-in-the-science-town-of-koltsovo-research-center-develops-and-produces-nutritional-supplements-cosmetic-formulations-biologically-active-substances-for-plants-and-the-antoshka-blackboard-chalks-kirill-kukhmartass-credit-itar-tass-news-agencyalamy-live-news-image264700852.html Biotechnological and plant research. Conceptual image. Biotechnological and plant research. Conceptual image.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/biotechnological-and-plant-research-conceptual-image-image330963375.html Next page Recent searches: Search Results for Biotechnological Stock Photos and Images  (989) Page 1 of 10 12345678910